New research builds on scientific understanding of how air pollution and cancer risk are distributed throughout the U.S. Air pollution, often resulting from industrial or vehicle emissions, can travel ...

Claire underwent surgery to remove the melanoma and was told she was cancer-free but two years later she felt a lump in her stomach ...

A study from the University of Michigan Health Rogel Cancer Center may have, at last, cracked the cold case of immunotherapy ...

Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...

At ESMO 2024, Dr. Andrea Necchi presented the results of an interim analysis of SunRISe-4, noting a pathological complete response rate in the combination arm of 42% and pathologic objective response ...

Join us to explore the latest insights into the future of precision oncology! This year, the Agilent Precision Oncology ...

Glioblastoma is the deadliest form of brain cancer, with less than a 5% five-year survival rate. One of the key contributors ...

The company reached a deal to divest its third biosimilar this year, selling a copycat version of Amgen’s Neulasta for up to ...

In the study, the firm will enroll previously treated patients whose tumors are positive for FRα based on IHC testing.

With upwards of a 41% increase in shares over the past five days and over 20.6% in the past month, Janux Therapeutics ( ...